Cancer chemotherapy optimization under evolving drug resistance.
From MaRDI portal
Publication:1875062
DOI10.1016/S0362-546X(01)00184-5zbMath1042.92508OpenAlexW2055063889MaRDI QIDQ1875062
Jaroslaw Smieja, Andrzej Swierniak
Publication date: 26 August 2004
Published in: Nonlinear Analysis. Theory, Methods \& Applications. Series A: Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/s0362-546x(01)00184-5
Applications of optimal control and differential games (49N90) Medical applications (general) (92C50)
Related Items (11)
On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach ⋮ Optimal Control of Cancer Treatments: Mathematical Models for the Tumor Microenvironment ⋮ The local and global dynamics model of a cancer tumor growth ⋮ Stochastic modeling of drug resistance in cancer ⋮ Modeling of drug resistance: Comparison of two hypotheses for slowly proliferating tumors on the example of low‐grade gliomas ⋮ Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model ⋮ The dynamics of an optimally controlled tumor model: A case study ⋮ Sufficient conditions for strong local optimality in optimal control problems with \(L_{2}\)-type objectives and control constraints ⋮ Dynamics and control of a mathematical model for metronomic chemotherapy ⋮ On the role of tumor heterogeneity for optimal cancer chemotherapy ⋮ A 3-compartment model for chemotherapy of heterogeneous tumor populations
This page was built for publication: Cancer chemotherapy optimization under evolving drug resistance.